Functional assessment of the engraftment potential of gammaretrovirus- modified CD34+ cells, using a short serum-free transduction protocol

Human Gene Therapy

Volumn 17, Issue 7, 2006, Pages 780-794

  Budak Alpdogan, Tulin ^a,b   Przybylowski, Mark ^b   Gonen, Mithat ^b   Sadelain, Michel ^b   Bertino, Joseph ^a   Rivière, Isabelle ^b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; VIRUS VECTOR;

ANIMAL EXPERIMENT; ARTICLE; ASSAY; BLOOD CELL; CELL CULTURE; CELL FUNCTION; CELL SURVIVAL; CELL TRANSPLANTATION; COMPETITIVE REPOPULATION ASSAY; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; GAMMARETROVIRUS VECTOR; GENE EXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROGENY; RETROVIRUS; SCID MOUSE; SERUM; TIME; TRANSGENE;

ANIMALS; ANTIGENS, CD34; BLOOD CELLS; CATTLE; CELL CULTURE TECHNIQUES; FEMALE; GAMMARETROVIRUS; GENE THERAPY; GENETIC VECTORS; HUMANS; MICE; MICE, INBRED STRAINS; SERUM; STEM CELL FACTOR; TETRAHYDROFOLATE DEHYDROGENASE; TRANSDUCTION, GENETIC; TRANSGENES;

GAMMARETROVIRUS;

EID: 33746239571     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2006.17.780     Document Type: Article

References (63)

1. + cells purified from granulocyte colony-stimulating factor (G-CSF)-mobilized infant and cord blood. Exp. Hematol. 25, 966-971.
2. + cells. Exp. Hematol. 24, 738-747.
3. ANDREADIS, S., FULLER, A.O., and PALSSON, B.O. (1998). Cell cycle dependence of retroviral transduction: An issue of overlapping time scales. Biotechnol. Bioeng. 58, 272-281.
4. ANDREADIS, S., LAVERY, T., DAVIS, H.E., LE DOUX, J.M., YARMUSH, M.L., and MORGAN, J.R. (2000). Toward a more accurate quantitation of the activity of recombinant retroviruses: Alternatives to titer and multiplicity of infection. J. Virol. 74, 1258-1266.
5. BALDUCCI, E., AZZARELLO, G., VALENTI, M.T., CAPUZZO, G.M., PAPPAGALLO, G.L., PILOTTI, I., AUSONI, S., BARI, M., ROSETTI, F., SARTORI, D., CIAPPA, A., PORCELLINI, A., and VINANTE, O. (2003). The impact of progenitor enrichment, serum, and cytokines on the ex vivo expansion of mobilized peripheral blood stem cells: A controlled trial. Stem Cells 21, 33-40.
6. BARRETTE, S., DOUGLAS, J., ORLIC, D., ANDERSON, S.M., SEIDEL, N.B., MILLER, A.D., and BODINE, D.M. (2000). Superior transduction of mouse hematopoietic stem cells with 10A1 and VSV-G pseudotyped retrovirus vectors. Mol. Ther. 1, 330-338.
7. BUDAK-ALPDOGAN, T., ALPDOGAN, O., BANERJEE, D., WANG, E., MOORE, M.A., and BERTINO, J.R. (2004). Methotrexate and cytarabine inhibit progression of human lymphoma in NOD/SCID mice carrying a mutant dihydrofolate reductase and cytidine deaminase fusion gene. Mol. Ther. 10, 574-584.
8. - bone marrow cells. J. Biochem. (Tokyo) 130, 331-334.
9. DAVIS, H.E., MORGAN, J.R., and YARMUSH, M.L. (2002). Polybrene increases retrovirus gene transfer efficiency by enhancing receptor-independent virus adsorption on target cell membranes. Biophys. Chem. 97, 159-172.
10. DAVIS, H.E., ROSINSKI, M., MORGAN, J.R., and YARMUSH, M.L. (2004). Charged polymers modulate retrovirus transduction via membrane charge neutralization and virus aggregation. Biophys. J. 86, 1234-1242.
11. DEMAISON, C., BROUNS, G., BLUNDELL, M.P., GOLDMAN, J.P., LEVINSKY, R.J., GREZ, M., KINNON, C., and THRASHER, A.J. (2000). A defined window for efficient gene marking of severe combined immunodeficient-repopulating cells using a gibbon ape leukemia virus-pseudotyped retroviral vector. Hum. Gene Ther. 11, 91-100.
12. + cells. Mol. Ther. 3, 359-367.
13. - cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: Dissociation of SRC phenotype and function. Blood 95, 102-110.
14. ECKERT, H.G., KUHLCKE, K., SCHILZ, A.J., LINDEMANN, C., BASARA, N., FAUSER, A.A., and BAUM, C. (2000). Clinical scale production of an improved retroviral vector expressing the human multidrug resistance 1 gene (MDR1). Bone Marrow Transplant. 25(Suppl. 2), S114-S117.
15. EFRON, B., and TIBSHIRANI, R.J. (1993). An Introduction to the Bootstrap. (Chapman-Hall, New York).
16. FORESTELL, S.P., BOHNLEIN, E., and RIGG, R.J. (1995). Retroviral end-point titer is not predictive of gene transfer efficiency: Implications for vector production. Gene Ther. 2, 723-730.
17. GALLARDO, H.F., TAN, C., ORY, D., and SADELAIN, M. (1997). Recombinant retroviruses pseudotyped with the vesicular stomatitis virus G glycoprotein mediate both stable gene transfer and pseudotransduction in human peripheral blood lymphocytes. Blood 90, 952-957.
18. GASPAR, H.B., PARSLEY, K.L., HOWE, S., KING, D., GILMOUR, K.C., SINCLAIR, J., BROUNS, G., SCHMIDT, M., VON KALLE, C., BARINGTON, T., JAKOBSEN, M.A., CHRISTENSEN, H.O., AL GHONAIUM, A., WHITE, H.N., SMITH, J.L., LEVINSKY, R.J., ALI, R.R., KINNON, C., and THRASHER, A.J. (2004). Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 364, 2181-2187.
19. + cells in non-obese diabetic/severe combined immune-deficient mice. Blood 92, 2641-2649.
20. + cells with HIV-1-derived lentiviral vectors. Mol. Ther. 2, 71-80.
21. + hematopoietic cells. Hum. Gene Ther. 8, 2193-2206.
22. HENNEMANN, B., CONNEALLY, E., PAWLlUK, R., LEBOULCH, P., ROSE-JOHN, S., REID, D., CHUO, J.Y., HUMPHRIES, R.K., and EAVES, C.J. (1999). Optimization of retroviral-mediated gene transfer to human NOD/SCID mouse repopulating cord blood cells through a systematic analysis of protocol variables. Exp. Hematol. 27, 817-825.
23. HENNEMANN, B., OH, I.H., CHUO, J.Y., KALBERER, C.P., SCHLEY, P.D., ROSE-JOHN, S., HUMPHRIES, R.K., and EAVES, C.J. (2000). Efficient retrovirus-mediated gene transfer to transplantable human bone marrow cells in the absence of fibronectin. Blood 96, 2432-2439.
24. KIEM, H.P., HEYWARD, S., WlNKLER, A., POTTER, J., ALLEN, J.M., MILLER, A.D., and ANDREWS, R.G. (1997). Gene transfer into marrow repopulating cells: Comparison between amphotropic and gibbon ape leukemia virus pseudotyped retroviral vectors in a competitive repopulation assay in baboons. Blood 90, 4638-4645.
25. KLUGE, K.A., BONIFACINO, A.C., SELLERS, S., AGRICOLA, B.A., DONAHUE, R.E., and DUNBAR, C.E. (2002). Retroviral transduction and engraftment ability of primate hematopoietic progenitor and stem cells transduced under serum-free versus serum-containing conditions. Mol. Ther. 5, 316-322.
26. KOTANI, H., NEWTON, P.B., III, ZHANG, S., CHIANG, Y.L., OTTO, E., WEAVER, L., BLAESE, R.M., ANDERSON, W.F., and MCGARRITY, G.J. (1994). Improved methods of retroviral vector transduction and production for gene therapy. Hum. Gene Ther. 5, 19-28.
27. KUHLCKE, K., FEHSE, B., SCHILZ, A., LOGES, S., LINDEMANN, C., AYUK, F., LEHMANN, F., STUTE, N., FAUSER, A.A., ZANDER, A.R., and ECKERT, H.G. (2002). Highly efficient retroviral gene transfer based on centrifugation-mediated vector preloading of tissue culture vessels. Mol. Ther. 5, 473-478.
28. KURRE, P., MORRIS, J., MILLER, A.D., and KIEM, H.P. (2001). Envelope fusion protein binding studies in an inducible model of retrovirus receptor expression and in CD34+ cells emphasize limited transduction at low receptor levels. Gene Ther. 8, 593-599.
29. KUSTIKOVA, O.S., WAHLERS, A., KUHLCKE, K., STAHLE, B., ZANDER, A.R., BAUM, C., and FEHSE, B. (2003). Dose finding with retroviral vectors: Correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population. Blood 102, 3934-3937.
30. KWON, Y.J., and PENG, C.A. (2002). Transduction rate constant as more reliable index quantifying efficiency of retroviral gene delivery. Biotechnol. Bioeng. 77, 668-677.
31. KWON, Y.J., HUNG, G., ANDERSON, W.F., PENG, C.A., and YU, H. (2003). Determination of infectious retrovirus concentration from colony-forming assay with quantitative analysis. J. Virol. 77, 5712-5720.
32. + cells. Blood Cells 20, 404-410.
33. LEBKOWSKI, J.S., SCHAIN, L.R., and OKARMA, T.B. (1995). Serum-free culture of hematopoietic stem cells: A review. Stem Cells 13, 607-612.
34. MAZURIER, F., GAN, O.I., MCKENZIE, J.L., DOEDENS, M., and DICK, J.E. (2004). Lentivector-mediated clonal tracking reveals intrinsic heterogeneity in the human hematopoietic stem cell compartment and culture-induced stem cell impairment. Blood 103, 545-552.
35. MILLER, A.D., GARCIA, J.V., VON SUHR, N., LYNCH, C.M., WILSON, C., and EIDEN, M.V. (1991). Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J. Virol. 65, 2220-2224.
36. MORGAN, J.R., LEDOUX, J.M., SNOW, R.G., TOMPKINS, R.G., and YARMUSH, M.L. (1995). Retrovirus infection: Effect of time and target cell number. J. Virol. 69, 6994-7000.
37. MORITZ, T., PATEL, V.P., and WILLIAMS, D.A. (1994). Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors. J. Clin. Invest. 93, 1451-1457.
38. MORITZ, T., DUTT, P., XIAO, X., CARSTANJEN, D., VIK, T., HANENBERG, H., and WILLIAMS, D.A. (1996). Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: Evidence of direct viral binding to chymotryptic carboxyterminal fragments. Blood 88, 855-862.
39. MURRAY, L., LUENS, K., TUSHINSKI, R., JIN, L., BURTON, M., CHEN, J., FORESTELL, S., and HILL, B. (1999). Optimization of retroviral gene transduction of mobilized primitive hematopoietic progenitors by using thrombopoietin, Flt3, and Kit ligands and RetroNectin culture. Hum. Gene Ther. 10, 1743-1752.
40. ORLIC, D., GIRARD, L.J., JORDAN, C.T., ANDERSON, S.M., CLINE, A.P., and BODINE, D.M. (1996). The level of mRNA encoding the amphotropic retro virus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction. Proc. Natl. Acad. Sci. U.S.A. 93, 11097-11102.
41. ORLIC, D., GIRARD, L.J., ANDERSON, S.M., BARRETTE, S., BROXMEYER, H.E., and BODINE, D.M. (1999). Amphotropic retrovirus transduction of hematopoietic stem cells. Ann. N. Y. Acad. Sci. 872, 115-123; discussion 123-114.
42. + peripheral blood stem cells in patients with X-linked chronic granulomatous disease. J. Hematother. Stem Cell Res. 11, 683-694.
43. PETZER, A.L., HOGGE, D.E., LANDSDORP, P.M., REID, D.S., and EAVES, C.J. (1996). Self-renewal of primitive human hematopoietic cells (long-term-culture- initiating cells) in vitro and their expansion in defined medium. Proc. Natl. Acad. Sci. U.S.A. 93, 1470-1474.
44. POLLOK, K.E., and WILLIAMS, D.A. (1999). Facilitation of retrovirus-mediated gene transfer into hematopoietic stem and progenitor cells and peripheral blood T-lymphocytes utilizing recombinant fibronectin fragments. Curr. Opin. Mol. Ther. 1, 595-604.
45. POLLOK, K.E., VAN DER LOO, J.C., COOPER, R.J., HARTWELL, J.R., MILES, K.R., BREESE, R., WILLIAMS, E.P., MONTEL, A., SESHADRI, R., HANENBERG, H., and WILLIAMS, D.A. (2001). Differential transduction efficiency of SCID-repopulating cells derived from umbilical cord blood and granulocyte colony-stimulating factor-mobilized peripheral blood. Hum. Gene Ther. 12, 2095-2108.
46. + cell selection in stroma-free cultures. Hematol. Cell Ther. 39, 49-58.
47. PRZYBYLOWSKI, M., HAKAKHA, A., STEFANSKI, J., HODGES, J., SADELAIN, M., and RIVIERE, I. (2006). Production scale-up and validation of packaging cell clearance of clinical-grade retroviral vector stocks produced in Cell Factories. Gene Ther. 13, 95-100.
48. REEVES, L., SMUCKER, P., and CORNETTA, K. (2000). Packaging cell line characteristics and optimizing retroviral vector liter: The National Gene Vector Laboratory experience. Hum. Gene Ther. 11, 2093-2103.
49. + cells on fibronectin fragment CH-296 is inhibited by high concentrations of vector containing medium. J. Gene Med. 3, 207-218.
50. + cells increases gene transfer mediated by GALV pseudotyped vectors. Mol. Ther. 6, 400-406.
51. RELANDER, T., KARLSSON, S., and RICHTER, J. (2002b). Oncoretroviral gene transfer to NOD/SCID repopulating cells using three different viral envelopes. J. Gene Med. 4, 122-132.
52. + cells using amphotropic-, GALV-, or RD114-pseudotyped HIV-1-based vectors from stable producer cells. Mol. Ther. 11, 452-459.
53. RIVIÈRE, I., BROSE, K., and MULLIGAN, R.C. (1995). Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc. Natl. Acad. Sci. U.S.A. 92, 6733-6737.
54. ROE, T., REYNOLDS, T.C., YU, G., and BROWN, P.O. (1993). Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12, 2099-2108.
55. SABATINO, D.E., DO, B.Q., PYLE, L.C., SEIDEL, N.B., GIRARD, L.J., SPRATT, S.K., ORLIC, D., and BODINE, D.M. (1997). Amphotropic or gibbon ape leukemia virus retrovirus binding and transduction correlates with the level of receptor mRNA in human hematopoietic cell lines. Blood Cells Mol. Dis. 23, 422-433.
56. SCHILZ, A.J., KUHLCKE, K., FAUSER, A.A., and ECKERT, H.G. (2001). Optimization of retroviral vector generation for clinical application. J. Gene Med. 3, 427-436.
57. SEKHAR, M., YU, J.M., SOMA, T., and DUNBAR, C.E. (1997). Murine long-term repopulating ability is compromised by ex. vivo culture in serum-free medium despite preservation of committed progenitors. J. Hematother. 6, 543-549.
58. SEPPEN, J., KIMMEL, R.J., and OSBORNE, W.R. (1997). Serum-free production, concentration and purification of recombinant retroviruses. Biotechniques 23, 788-790.
59. TISDALE, J.F., HANAZONO, Y., SELLERS, S.E., AGRICOLA, B.A., METZGER, M.E., DONAHUE, R.E., and DUNBAR, C.E. (1998). Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability. Blood 92, 1131-1141.
60. TRARBACH, T., GREIFENBERG, S., BARDENHEUER, W., ELMAAGACLI, A., HIRCHE, H., FLASSHOVE, M., SEEBER, S., and MORITZ, T. (2000). Optimized retroviral transduction protocol for human progenitor cells utilizing fibronectin fragments. Cytotherapy 2, 429-438.
61. TUSCHONG, L., SOENEN, S.L., BLAESE, R.M., CANDOTTI, F., and MUUL, L.M. (2002). Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy. Hum. Gene Ther. 13, 1605-1610.
62. VAN DER LOO, J.C., LIU, B.L., GOLDMAN, A.I., BUCKLEY, S.M., and CHRUDIMSKY, K.S. (2002). Optimization of gene transfer into primitive human hematopoietic cells of granulocyte-colony stimulating factor-mobilized peripheral blood using low-dose cytokines and comparison of a gibbon ape leukemia virus versus an RD114-pseudotyped retroviral vector. Hum. Gene Ther. 13, 1317-1330.
63. ZIELSKE, S.P., and GERSON, S.L. (2003). Cytokines, including stem cell factor alone, enhance lentiviral transduction in nondividing human LTCIC and NOD/SCID repopulating cells. Mol. Ther. 7, 325-333.